(Q53890280)
Statements
Her2/neu-positive disease does not increase risk of locoregional recurrence for patients treated with neoadjuvant doxorubicin-based chemotherapy, mastectomy, and radiotherapy. (English)
Kelly K Hunt
Gabriel N Hortobagyi
Aman U Buzdar
Thomas A Buchholz
Eugene H Huang
Donald Berry
Lajos Pusztai
Eric A Strom
Marsha D McNeese
George H Perkins
Naomi R Schechter
Henry M Kuerer
Vicente Valero
Aysegul A Sahin
1 August 2004
59
5
1337-1342